Immunogenicity 15191
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
RING1
Transcript ID
uc003odl.3
HLA INFO
B*38:01
TCR INFO
No TCR info found!
Full length protein sequence (377 aa)
MDGTE
1
IAVSP
6
RSLHS
11
ELMCP
16
ICLDM
21
LKNTM
26
TTKEC
31
LHRFC
36
SDCIV
41
TALRS
46
GNKEC
51
PTCRK
56
KLVSK
61
RSLRP
66
DPNFD
71
ALISK
76
IYPSR
81
EEYEA
86
HQDRV
91
LIRLS
96
RLHNQ
101
QALSS
106
SIEEG
111
LRMQA
116
MHRAQ
121
RVRRP
126
IPGSD
131
QTTTM
136
SGGEG
141
EPGEG
146
EGDGE
151
DVSSD
156
SAPDS
161
APGPA
166
PKRPR
171
GGGAG
176
GSSVG
181
TGGGG
186
TGGVG
191
GGAGS
196
EDSGD
201
RGGTL
206
GGGTL
211
GPPSP
216
PGAPS
221
PPEPG
226
GEIEL
231
VFRPH
236
PLLVE
241
KGEYC
246
QTRYV
251
KTTGN
256
ATVDH
261
LSKYL
266
ALRIA
271
LERRQ
276
QQEAG
281
EPGGP
286
GGGAS
291
DTGGP
296
DGCGG
301
EGGGA
306
GGGDG
311
PEEPA
316
LPSLE
321
GVSEK
326
QYTIY
331
IAPGG
336
GAFTT
341
LNGSL
346
TLELV
351
NEKFW
356
KVSRP
361
LELCY
366
APTKD
371
PK
376
Mutation Information
DNA mutation:
None
Peptide Range:
281 ~ 305
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"QQEAGEPGGPGGGASDTGGPDGCGG
||||||||||||.||||||||||||
Mutant:
QQEAGEPGGPGGSASDTGGPDGCGG"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) RING1
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay